NULL
3Q23
Articles related to 3Q23
Preliminary 3Q23 Financial Results: Action Reports NP in Line with Forecasts
Miraculum's 3Q23 Results Surpass Expectations with Strong EBITDA and Improved Gross Margin
Analysis of 3Q23 Results: Gross Profit Decline, Operating Expenses, and Receivable Challenges
3Q23 Revenues Report: Bioton Sees a 12% YoY Decline, Driven by Insulin Sales Drop of 18%
Mabion 3Q23 Earnings Forecast: Positive EBIT Amid Shutdown, Revenue Projection at PLN 25 Million
